Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...
U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...
Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...
Securing a prescription for GLP-1s can be pricey — and not to mention, sometimes quite frustrating and invasive. But safety ...
A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
A new study suggests that semaglutide, a blockbuster anti-obesity GLP-1 drug, could help people cut down on addictive behavior and prevent opioid overdose.
Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's ...
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback